Scribd
Upload
46 views

Peralta - Melchizedek CT

The document summarizes a study on the incidence of diabetes mellitus in Italy in 2018. Some key findings were that the incidence reached about 5 per 1000 people, with nearly 10% of all diabetes cases being new cases in 2018. Non-insulin medications were nearly 10 times more common treatments than insulin. Most new cases were in people over age 40, and noninsulin-treated diabetes was much more prevalent than insulin-treated diabetes.

Uploaded by

Paola Cruz
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
46 views

Peralta - Melchizedek CT

The document summarizes a study on the incidence of diabetes mellitus in Italy in 2018. Some key findings were that the incidence reached about 5 per 1000 people, with nearly 10% of all diabetes cases being new cases in 2018. Non-insulin medications were nearly 10 times more common treatments than insulin. Most new cases were in people over age 40, and noninsulin-treated diabetes was much more prevalent than insulin-treated diabetes.

Uploaded by

Paola Cruz
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 2

Melchizedek N.

Peralta
BSN 3Y2- Irregular 1

COURSE TASK

Incidence of diabetes mellitus in Italy in year 2018. A nationwide population-based study


of the ARNO Diabetes Observatory
https://www.sciencedirect.com/science/article/pii/S0939475321001873

Some of the highlights of this study is the incidence of diabetes in Italy that reached
about 5 per 1000 person. I know it sounds a small percentage but if you’d think about the total
number of it in their total population. It would bring up a very big number with diabetes. In 2018,
incident cases of diabetes accounted for almost 10% of all diabetes cases detected. Cases
treated with non-insulin medications are nearly ten times more common than those treated with
insulin. Women aged 11–40 years had a larger incidence than men of the same age, as well as
men vs. women aged >40 years.
Interestingly, the rates were equal in men and women in the first two decades, but they
were greater in women in the third and fourth decades, owing to the use of insulin in GDM. In
the fifth decade, rates were similar, then higher in men, before returning to similar in the oldest
patients. Surprisingly, up to 70% of incident participants were above the age of 40.
In conclusion, this study reveals that new instances of diabetes in Italy number in the
hundreds of thousands per year, accounting for a significant share of the diabetic population.
Noninsulin-treated diabetes was nearly ten times more common than insulin-treated diabetes,
while the majority of incident insulin-treated individuals were mature, elderly, or elderly.
Medical treatment of type 2 diabetes mellitus: Recommendations of the Diabetes,
Obesity and Nutrition Group of the Spanish Society of Internal Medicine
https://www.sciencedirect.com/science/article/pii/S2254887420301557

This study in Spain about diabetes was created because of its high prevalence and
morbidity, type 2 diabetes is a major public health concern. Medical treatment is becoming
increasingly sophisticated, with an emphasis on the clinical circumstances of patients. The
Working Group of Diabetes, Obesity, and Nutrition of the Spanish Society of Internal Medicine
issued a consensus statement on medical management of type-2 diabetes in this article. The
goal of this agreement is to make treatment decision-making easier for diabetes patients.
Treatments for cardiovascular disease, particularly heart failure, are prioritized in the paper.
It is also recommended that Metformin remains the first line of anti-diabetic therapy, and
it must be prescribed if there is no intolerance or contraindication. The negative effects of
hypoglycemia and other adverse effects are more severe in elderly persons. As a result, more
lenient glycemic management goals must be provided. In aged individuals, however, there is
evidence of CV, renal, and HF advantages.
I have come to observed while reading this article that the purpose of this document is to
enhance proper antidiabetic medicine prescriptions in any sector of the healthcare system in
order to improve prognosis and reduce complications in patients with DM2.

You might also like